ACM
APLS

ADAR1 Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

ADAR1 Capital Management’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$3.84K – 285
2024
Q2 		$3.84K Buy
+100
New +$4.53K ﹤0.01% 249

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADAR1 Capital Management's APLS Position: Q2 2026 in Review

ADAR1 Capital Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 72,500 shares — an estimated $2.92M sold.

ADAR1 Capital Management first reported a position in APLS in Q1 2024 and held it in 9 quarters. The position peaked at $2.92M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • ADAR1 Capital Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • ADAR1 Capital Management sold 72,500 Apellis Pharmaceuticals shares in Q2 2026, an estimated $2.92M.
  • ADAR1 Capital Management first reported a position in Apellis Pharmaceuticals in Q1 2024 and held it in 9 quarters.
  • ADAR1 Capital Management's Apellis Pharmaceuticals position peaked at $2.92M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.